Emergency
+91 9924023456
+91 9904722345
+91 9913460101
+91 9824344554

Know your Doctor

Home » Know your Doctor

Dr. Priyanshu Choudhary

Refer Doctor

Consultant Oncologist
MBBS , MD (Internal medicine ) , DM (Medical Oncology)

Specialities

Oncology

Hospitals

Shalby Hospital Mohali

Dr. Priyanshu Choudhary is a Medical Oncologist in Phase 9, Mohali and has an experience of 5 years in this field. Dr. Priyanshu Choudhary practices at Shalby Multi-Speciality Hospital in Phase 9, Mohali. He completed MD from University of Delhi and DM – Medical Oncology from All India Institute of Medical Sciences, New Delhi

Professional Qualification

  • MBBS
  • MD (Internal medicine ) Lady Hardinge MedicalCollege  , Delhi
  • DM (Medical Oncology) -BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi

Conferance & workshops

  • Attended MSK-Pfizer India Breast Oncology Virtual Seminar on Nov 19 & 20, 2021

Membership

  • American Society of Clinical Oncology(ASCO)
  • European Society for Medical Oncology (ESMO)
  • Indian Society of Medical and Pediatric Oncology(ISMPO)

Area of expertise

  • BREAST CANCER
  • LUNG CANCER
  • HEAD AND NECK CANCER
  • PEDIATRIC CANCER
  • LEUKEMIA AND LYMPHOMAS
  • COLON , STOMACH ,GALL BLADDER AND PANCREATIC CANCER
  • OVARY AND CERVIX CANCER
  • PROSTATE AND BLADDER CANCER
  • SARCOMA
  • MULTIPLE MYELOMA
  • BONE MARROW TRANSPLANT
  • Treatment and counselling of patients receiving cancer therapy for solid and hematological malignancies
  • Targeted therapy, Immunotherapy, Chemotherapy and Hormonal therapy
  • PICC line insertion, bone marrow aspiration and biopsy, lumbar puncture, FNACs
  • Autologous stem cell transplant for hematological malignancies
  • Familial and hereditary cancer treatment, screening with genetic counselling
  • Palliative and supportive care for advanced cancer patients

Publications

  • 1 Choudhary P, Gogia A, Deo S, Mathur S, Sharma D. Neoadjuvant chemotherapy in locally advanced breast cancer: Clinicopathological characteristics and correlation with pathological complete response. JCO. 2020 May 20;38(15_suppl):e12658–e12658.
  • 2 Garg A, Batra U, Choudhary P, Jain D, Khurana S, Malik PS, et al. Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lungcancer: A real-world multicentric cohort analysis from India. Current Problems in Cancer. 2020;44(3):100570.
  • 3 Nevrekar VV, Choudhary P, Tiwari A, Suryaprakash V, Upadhyay A. Impact of serum galactomannan assay on diagnosis and outcome of invasive fungal infections in high risk febrile neutropenia: A prospective cohort study. Annals of Oncology. 2020 Sep 1;31:S65
  • 4 Arora, S, Pushpam, D, Tiwari, A,Choudhary P, et al. Allogeneic hematopoietic stem cell transplant in pediatric acute myeloid leukemia: Lessons learnt from a tertiary care center in India. Pediatr Transplant. 2020; 00:e13918.
  • 5 Patel A, Batra U, Prasad KT, Dabkara D, Ghosh J, Sharma M, Choudhary P et al. Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from India. Current Problems in Cancer. 2020 Jun 1;44(3):100571.
SHALBY HOSPITAL
Corporate Office :

B-301/302,Mondeal Heights,
S. G. Highway,
Ahmedabad 380015,
Gujarat , India

We're Socially Active!

SHALBY GROUP
Subscribe To Newsletter
arrow Icon

© 2024 Shalby Hospitals , Inc. All rights reserved